{"id":2068,"date":"2021-11-18T17:27:36","date_gmt":"2021-11-18T17:27:36","guid":{"rendered":"https:\/\/www.impactafricasummit.org\/?page_id=2068"},"modified":"2021-11-23T01:26:50","modified_gmt":"2021-11-23T01:26:50","slug":"dr-lutchmee-nobaub","status":"publish","type":"page","link":"https:\/\/www.impactafricasummit.org\/pias\/ias-pharma-2021-speakers\/dr-lutchmee-nobaub\/","title":{"rendered":"Dr. Lutchmee Nobaub"},"content":{"rendered":"<div id=\"mediapat\">\n<div class=\"mdpatleft\">\n<img loading=\"lazy\" decoding=\"async\" width=\"500\" height=\"500\" src=\"https:\/\/www.impactafricasummit.org\/wp-content\/uploads\/2021\/11\/Dr.-Lutchmee-Nobaub.jpg\" alt=\"Dr. Lutchmee Nobaub\" class=\"alignnone size-full wp-image-2069\" srcset=\"https:\/\/www.impactafricasummit.org\/pias\/wp-content\/uploads\/2021\/11\/Dr.-Lutchmee-Nobaub.jpg 500w, https:\/\/www.impactafricasummit.org\/pias\/wp-content\/uploads\/2021\/11\/Dr.-Lutchmee-Nobaub-300x300.jpg 300w, https:\/\/www.impactafricasummit.org\/pias\/wp-content\/uploads\/2021\/11\/Dr.-Lutchmee-Nobaub-150x150.jpg 150w, https:\/\/www.impactafricasummit.org\/pias\/wp-content\/uploads\/2021\/11\/Dr.-Lutchmee-Nobaub-100x100.jpg 100w\" sizes=\"auto, (max-width: 500px) 100vw, 500px\" \/>\n<\/div>\n<div class=\"mdpatright\">\n<h2>Dr. Lutchmee Nobaub<\/h2>\n<p style=\"margin-top:-15px;\">CEO, Clinear Research<\/p>\n<p>&nbsp;<br \/>\n<strong>FACILITATOR<\/strong><br \/>\n&nbsp;<\/p>\n<p>CEO Clinear Research (Mauritius\/France)\u00a0<\/p>\n<p>Within 14 years\u2019 experience in clinical research in pharmaceutical companies\/Contract Research Organizations (CROs) and hospitals, Lutchmee Nobaub has been working on numerous international phase I to phase IV multi-center trials in different indications, embracing all steps from qualification to termination in Western Europe, Mauritius, and Reunion.\u00a0<\/p>\n<p>In 2015, she founded Clinear Research, a Mauritian CRO, covering different therapeutic areas. It provides effective biopharmaceutical services, as well as clinical investigation solutions to other CROs,\u00a0pharmaceutical laboratories, and medical device manufacturers.\u00a0\u00a0<\/p>\n<p>Lutchmee Nobaub, initially created Clinear Research to compensate for the lack of local expert clinical research associates (CRA) in the sub-region, capable of supervising clinical studies on site. In the last 6 years, she has been training local physicians and medical staff to the Clinical Research exigence in conformity with the ICH\/GCP, the European directives, and the\u00a0 Mauritian regulations. Her Clinear Research\u2019s team has already worked in numerous international studies in Lupus, NASH, Hepatitis, Dermatology, glaucoma, obesity, pre-eclampsia, as well as in medical devices.\u00a0<\/p>\n<p>In November\u00a02021, her effort was rewarded by the Woman In Africa, where she\u00a0was the health revelation 2021.\u00a0<\/p>\n<p>Her values: Patient, People, Procedures, the 3 Ps to bring the best of breed clinical research worldwide. She is personally involved in the achievement of her teams\u2019 work, with efficiency and empathy, and a constant concern for the patient\u2019s interest.<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Lutchmee Nobaub CEO, Clinear Research &nbsp; FACILITATOR &nbsp; CEO Clinear Research (Mauritius\/France)\u00a0 Within 14 years\u2019 experience in clinical research in pharmaceutical companies\/Contract Research Organizations (CROs) and hospitals, Lutchmee Nobaub has been working on numerous international phase I to phase IV multi-center trials in different indications, embracing all steps from qualification to termination in Western [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1019,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2068","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/pages\/2068","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/comments?post=2068"}],"version-history":[{"count":4,"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/pages\/2068\/revisions"}],"predecessor-version":[{"id":2133,"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/pages\/2068\/revisions\/2133"}],"up":[{"embeddable":true,"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/pages\/1019"}],"wp:attachment":[{"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/media?parent=2068"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}